Model 3 further included adjustments for hypertriglyceridemia, hypo-HDL cholesterolemia, hyper-LDL cholesterolemia, diabetes, chronic kidney disease, hyperuricemia, alanine aminotransferase, and aspartate aminotransferase, in addition to the covariates in Model 2. The gene discussed is GPT; the disease is chronic kidney disease.